I a p l a s t i c anemia (SAA), 18 had leukemia. A l l patients were conditioned with cyklophosphamide, leukemic children also had 10 GY of t o t a l body i r r a d i a t i o n (TBI) delivered by a l i n e a r accelerator a t a mean dose r a t e <0,05 GYlmin.
BMT. The remaining 18 show a poor growth during the f i r s t year
I
The children who suffered from SAA have a l l grown normally a f t e r I a f t e r BMT. 7/18 deviated -1 SO or more. Growth hormone (GH) stimul a t i o n t e s t s with insulin and arginine were performed every year.
Though growth was poor the f i r s t year, 19/20 had a normal GH response. A t year t h r e e , however, 10118 f a i l e d t o respond normally.
'
To further investigate physiological GH secretion, 24 hour were done in 13 cases. In 5 of these, t h e r e was not one significan GH-peak (>8 u g / l ) . 4 children had one peak and 4 children had 3-5 peaks. Also when calculating the area over baseline, 7110 had ob- (NEJM 1983) . To describe the long term follow-up and the testosterone (T) deficiency we studied, with an i n t e r v a l time since TI >2ycs, 28 boys i r r a d i a t e d with 12X2Q' a t 4.8 t o 16.9 yrs, before (24) o r during (4) puberty. All but 4 received a l s o c r a n i a l prophylactic i r r a d i a t i o n . All but the 2 o l d e r s a t TI had leydig c e l l insufficiency manifested by a low T response t o hCG (7X1500U) and/or by increased basal plasma IJI (>5mIU/ml) when bone age (BA) >12yrs (n=21). The 8 p a t i e n t s with nonnal (2) o r compensated (6) T secretion had normal spontaneous v i r i l i s a t i o n with T between 4.3 and 8 ng/ml. This group included a l l the boys i r r a d i a t e d during puberty. Age a t TI and T/hCG were highly correlated (n=21, ~4 . 6 2 , p<0.001). I n 6 cases, a 2nd hCG t e s t performed a t i n t e r v a l s from 0.6 t o 5 . 5~3 , showed a response i d e n t i c a l t o the 1st t e s t (~4 . 9 9 ) . Similarly i n 8 cases having a 2nd evaluation a f t e r >2yrs, when BA>12yrs and I UI>5mIU/ml, a c o r r e l a t i o n was found between basal T and , repubertal T response t o hCG (r=0.79, p<0.01).
?n conclusion 1 ) The s e v e r i t y of leydig c e l l insufficiency is I
highly r e l a t e d t o age a t t e s t i c u l a r irradiation. 2) No signi-I f i c a n t change from the i n i t i a l evaluation was observed on , follow-up. 3) Spontaneous pubertal v i r i l i s a t i o n may occur and was usually permitted by compensated T insufficiency. 
7
Division of Cellular and Genetic Pathology,Cambridge University. Endocrine Unit F i r s t Oept. of Pediatrics Athens, University. ICHTHYOSIS(I) AND HYPOGONADISM(H) I N TWO BROTHERS WITH DELETION OF THE SHORT ARM OF THE X-CHROMOSOME. Two brothers aged 9.5(N) and 17 years(J) respectively, underwent b i l a t e r a l orcheopexy a t the age of 4 years and were recently exa mined f o r H. They were healthy.tall,of normal intelligence and they presented skin lesions of I. The testes were small (lml in N b i l a t e r a l l y , and i n . I R:lml, L:3-4ml). J. had receive, testosterone f o r 1 year and had Tanner 111 pubic hair. There was no response of serum testosterone t o HCG and no appreciable response of LH and FSH t o IV LHRH. Serum DHEAS values were 518 in N and 3700nglml in J. STS a c t i v i t y i n WBC was 0 pmols/hr/m~ protein in both subjects (control:24.9). Flow cytometry showed the X chromosome t o be 2-3% smaller than normal, indicating a large deletion of about 5 million base pairs. No hybridization t o the probe GMGX9 (DXS 237) was found, indicating steroid s u l f a t a s e (STS) gene deletion. There was hybridization t o the probe d i c 56 (OXS 143), which i s proximal t o STS. This puts a proximal limit on the extent of the deletion. They were heterozygous f o r the probe p19b a t the MICLX locus which puts a d i s t a l l i m i t on the deletion. Hence, in these two brothers with I and H , a large deletion of the short arm of the X chromosome was disclosed which included the STS locus, the closely linked locus OXS 237 and the gene f o r hypoponadism, findings which o f f e r the opportunity f o r speculations on the locus of control of n o n a l t e s t i c u l a r develooment and function.
V. H e a s e , C. F i s c h e rb e~a r t m e n t o f Y s e d i a t r i c e . U n i v e r s i t r o f ~e h e , UUR

3 m J E c T I o N s o P HcG ARE As EFFECTIVE As l o INJECTIONS I N THE TREATMENT OF CRYPTORCHI-UISM T r e a t m e n t o f c r y p t o r c h i d i e m w i t h GnRH p r e p a r a t i o n s has some d i e a d v a n t e g e s -i t r e q u i r e s d a i l y a p p l i c a t i o n s
o v e r 4 w e e k s a n d i n v o l v e 6 t h e u n c e r t a i n t y o f p a r e n t s 1 c o o p e r e t i o n . H C G t h e r a p y (i.m.1 is e e f e r b u t 1 0 i n j e ot i o n s a c c o r d i n g t o t h e IHF s c h e d u l e can n o l o n g e r b e a c c e p t e d . T h a t ' e why i n a n a l t e r n a t i v e s t u d y w h i c h Inc l u d e d 3 0 9 b o s w i t h c r y p t o r c h i d i e m ( 1 5 8 u n i l a t e r a l , 1 5 1 b i l a t e r a l $ , e HCG s c h e d u l e ( 1 ) w i t h 3 HCC i.m. inj e c t i o n e (1-3 yra-3x1000IU,3-6 y r s = 3 x 1 5 0 0 I U , 6-10 y r s =3x3000IU. 10-1 3~3~5 0 0 0 I U ; i n t e r v a l s = 7 -1 Odaye, n~1 4 6 ) a n d t h e IHF s c h e d u l e ( 1 1 ) w i t h 1 0 inj. i n age-depend e n t d o s a g e s n e 1 4 6 ) w e r e compared. C o m p l e t e d e s c e n t w a s s e e n i n 46,151 (30.5%) t e s t e s ( a b d o m i n a l , i n g u in a l r e t e n t i o n a n d p r e a c r o t a l t e s t e s u n d e r I a n d 80/ 2 0 3 t e s t e s (39.4%) u n d e r I1 ( p n . e . ] P a r t i a l d e e c e n t o c o u r e d i n 41% o f t h e c e s e e u n d e r I a n d 40.4% u n d e r 11. In p a t i e n t s w i t h a b d o m i n a l a n d i n g u i n a l r e t e n t i o n t h o p o s i t i v e r e e u l t e w e r e com a r a b l e i n t h e a g e g r o u p € 1-3 ( n u 1 2 4 ) a n d 3 -6 y r s ( n = l~l B , b u t in t h e a g e g r o u 6 -1 3 y r e (n-93) 1 0 i n j . w e r e more e f f e c t i v e ( p 4 0.057.
Follow-up r e e u l t e 2-9 m o n t h e a f t e r t h e r a p y w e r e n e a rl y i d e n t i c a l l y . Concl.:HCGtherapy w i t h 3 HCG i n j e c t .
is a s a f e a l t e r n m r o o e d u r e t o t h e CnRH t h e r a p y . (T) . Previous studies have shown that plasma T rises steadily for 4-5 days (d.) after a single hCC injection (inj.). This study was undertaken to test the hypothesis that it is unnecessary to repeat inj. before that peak. The proposed protocol (Rx) (1) consisted of 4 IM inj. of LOO IUIkg of hCC a t 4 (n = 16) or 5 d. intervals (n = 79). Results, being similar, are given in the total group (1) (n = 95) and compared to that of a previous Rx (11) using 7 inj. of I500 IU of hCC every 48 h (group 11, n = 440). The % of unilateral (UC; 60%) and bilateral cryptorchidism (BC; 40%) was identical in both groups. Success (complete descent) was recorded in 50.9% of UC and 50% of BC in group I, and 40.7% of UC and 36.7% of RC in group 11. Rate of relapse (at 1-4 yrs) was similar in group 1 (9%) and 11 (10%). Plasma T was measured respectively 4 and I d. after the last inj. in Rx I and 11. Mean ( S D ) T levels (ngldl) were not different whether Rx was successful or not, either with Rx l(392 t 207 and 430 + 207) or 11 (495 + 247 and 541 + 304). In total groups, T level:
were lower 6 = 0.003) w i t h x x 1 (410 + 267) than with Rx 11 (516 + 273), possibly due to a relatively late time of sampling in Rx I. Finally, T values were normally distributed in Rx I but not in Rx I1 (median being respectively 384 and 443). In conclusion, a Rx using hCG a t doses related to body size and inj. a t only 4-5 day intervals appears as efficient, or even more, as Rx using frequent hCG injections in the treatment of undescended testis.
